Foundation News

Stay up-to-date with the most current news and information about the Crohn's & Colitis Foundation, as well as Crohn's disease and ulcerative colitis.

Crohn’s & Colitis Foundation’s IBD Plexus Platform Confirms Findings on Need for Personalized Approach in Use of 5-ASA in Treating Inflammatory Bowel Disease

Using collective data made available by IBD Plexus, researchers’ findings advance the possibility of microbiome-based personalized medicine for IBD treatment

May 30, 2023

Crohn’s & Colitis Foundation Applauds Senate HELP Committee for Including the Safe Step Act in PBM Reform Legislation

Legislation will give patients and their doctors a process to seek exception to Step Therapy requirements that may delay necessary care

May 16, 2023

Crohn’s & Colitis Foundation Urges Congress To Pass Legislation to Reform Pharmacy Benefit Manager (PBM) Industry

The Crohn's & Colitis Foundation advocates for reform in the Pharmacy Benefit Manager (PBM) industry due to the negative impact it has on patients' access to medicine.

May 1, 2023

Crohn’s & Colitis Foundation Makes Statement in Support of FDA’s Role in Safeguarding Patients

Last week, in an unprecedented decision, a Texas federal judge invalidated the Food and Drug Administration’s (FDA) approval of a drug that was approved by the agency in 2000.

April 12, 2023

Crohn’s & Colitis Foundation Makes Statement About Crohn’s Disease Patient Fired from Walmart

April 3, 2023, New York, NY – Last week, the U.S. Equal Employment Opportunity Commission (EEOC) sued Walmart for firing a North Carolina employee with Crohn’s disease after the company allegedly refused to grant her disability-related leave.

April 4, 2023

Crohn’s & Colitis Foundation’s IBD Ventures Invests $2.4 Million in Developing Novel Products to Address Unmet Needs of IBD Patients

Since 2017, IBD Ventures Has Invested Over $9 Million In R&D Funding to Portfolio Companies

March 21, 2023

Early Life Stress in Mice Impairs Gut Immune Regulation and Leads to Worsened Future Colonic Inflammation

New York, NY, March 14, 2023 – Early life stress (ELS) in mice can disrupt the gut immune response, leading to longer-lasting intestinal inflammation and a worsened future disease state than control mice not exposed to ELS, according to a new study published in Inflammatory B

March 15, 2023

New National Survey Shows Lack of Public Restrooms is Widespread Public Health Issue

NEW YORK, NY, November 17, 2022 — A new survey of U.S.

November 17, 2022

Crohn’s & Colitis Foundation announces Sharon Lungrin as new member of senior leadership team

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today

July 18, 2022